BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 15052637)

  • 21. Functional promoter testing using a modified lentiviral transfer vector.
    Geller SF; Ge PS; Visel M; Greenberg KP; Flannery JG
    Mol Vis; 2007 May; 13():730-9. PubMed ID: 17563724
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use and comparison of different internal ribosomal entry sites (IRES) in tricistronic retroviral vectors.
    Douin V; Bornes S; Creancier L; Rochaix P; Favre G; Prats AC; Couderc B
    BMC Biotechnol; 2004 Jul; 4():16. PubMed ID: 15279677
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficient gene transfer to human peripheral blood monocyte-derived dendritic cells using human immunodeficiency virus type 1-based lentiviral vectors.
    Chinnasamy N; Chinnasamy D; Toso JF; Lapointe R; Candotti F; Morgan RA; Hwu P
    Hum Gene Ther; 2000 Sep; 11(13):1901-9. PubMed ID: 10986562
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-level recombinant protein production in CHO cells using lentiviral vectors and the cumate gene-switch.
    Gaillet B; Gilbert R; Broussau S; Pilotte A; Malenfant F; Mullick A; Garnier A; Massie B
    Biotechnol Bioeng; 2010 Jun; 106(2):203-15. PubMed ID: 20178120
    [TBL] [Abstract][Full Text] [Related]  

  • 25. pTRIDENT, a novel vector family for tricistronic gene expression in mammalian cells.
    Fussenegger M; Mazur X; Bailey JE
    Biotechnol Bioeng; 1998 Jan; 57(1):1-10. PubMed ID: 10099172
    [TBL] [Abstract][Full Text] [Related]  

  • 26. pLR: a lentiviral backbone series to stable transduction of bicistronic genes and exchange of promoters.
    Vargas JE; Salton G; Sodré de Castro Laino A; Pires TD; Bonamino M; Lenz G; Delgado-Cañedo A
    Plasmid; 2012 Nov; 68(3):179-85. PubMed ID: 22728068
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeted transgene expression in muller glia of normal and diseased retinas using lentiviral vectors.
    Greenberg KP; Geller SF; Schaffer DV; Flannery JG
    Invest Ophthalmol Vis Sci; 2007 Apr; 48(4):1844-52. PubMed ID: 17389520
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lentiviral vectors harboring a dual-gene system allow high and homogeneous transgene expression in selected polyclonal human embryonic stem cells.
    Ben-Dor I; Itsykson P; Goldenberg D; Galun E; Reubinoff BE
    Mol Ther; 2006 Aug; 14(2):255-67. PubMed ID: 16632408
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiply attenuated, self-inactivating lentiviral vectors efficiently transduce human coronary artery cells in vitro and rat arteries in vivo.
    Céfaï D; Simeoni E; Ludunge KM; Driscoll R; von Segesser LK; Kappenberger L; Vassalli G
    J Mol Cell Cardiol; 2005 Feb; 38(2):333-44. PubMed ID: 15698840
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High levels of transgene expression following transduction of long-term NOD/SCID-repopulating human cells with a modified lentiviral vector.
    Gao Z; Golob J; Tanavde VM; Civin CI; Hawley RG; Cheng L
    Stem Cells; 2001; 19(3):247-59. PubMed ID: 11359950
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-level recombinant protein production in CHO cells using an adenoviral vector and the cumate gene-switch.
    Gaillet B; Gilbert R; Amziani R; Guilbault C; Gadoury C; Caron AW; Mullick A; Garnier A; Massie B
    Biotechnol Prog; 2007; 23(1):200-9. PubMed ID: 17269689
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel lentiviral vectors with mutated reverse transcriptase for mRNA delivery of TALE nucleases.
    Mock U; Riecken K; Berdien B; Qasim W; Chan E; Cathomen T; Fehse B
    Sci Rep; 2014 Sep; 4():6409. PubMed ID: 25230987
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Critical factors influencing stable transduction of human CD34(+) cells with HIV-1-derived lentiviral vectors.
    Haas DL; Case SS; Crooks GM; Kohn DB
    Mol Ther; 2000 Jul; 2(1):71-80. PubMed ID: 10899830
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detailed design and comparative analysis of protocols for optimized production of high-performance HIV-1-derived lentiviral particles.
    Mitta B; Rimann M; Fussenegger M
    Metab Eng; 2005; 7(5-6):426-36. PubMed ID: 16102993
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 6-hydroxy-nicotine-inducible multilevel transgene control in mammalian cells.
    Malphettes L; Schoenmakers RG; Fussenegger M
    Metab Eng; 2006 Nov; 8(6):543-53. PubMed ID: 16962351
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lentiviral vectors for enhanced gene expression in human hematopoietic cells.
    Ramezani A; Hawley TS; Hawley RG
    Mol Ther; 2000 Nov; 2(5):458-69. PubMed ID: 11082319
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Highly efficient multicistronic lentiviral vectors with peptide 2A sequences.
    Ibrahimi A; Vande Velde G; Reumers V; Toelen J; Thiry I; Vandeputte C; Vets S; Deroose C; Bormans G; Baekelandt V; Debyser Z; Gijsbers R
    Hum Gene Ther; 2009 Aug; 20(8):845-60. PubMed ID: 19419274
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hybrid HIV/MSCV LTR enhances transgene expression of lentiviral vectors in human CD34(+) hematopoietic cells.
    Choi JK; Hoang N; Vilardi AM; Conrad P; Emerson SG; Gewirtz AM
    Stem Cells; 2001; 19(3):236-46. PubMed ID: 11359949
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo transduction of HIV-1-derived lentiviral particles engineered for macrolide-adjustable transgene expression.
    Mitta B; Weber CC; Fussenegger M
    J Gene Med; 2005 Nov; 7(11):1400-8. PubMed ID: 15999397
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-level transduction and gene expression in hematopoietic repopulating cells using a human immunodeficiency [correction of imunodeficiency] virus type 1-based lentiviral vector containing an internal spleen focus forming virus promoter.
    Demaison C; Parsley K; Brouns G; Scherr M; Battmer K; Kinnon C; Grez M; Thrasher AJ
    Hum Gene Ther; 2002 May; 13(7):803-13. PubMed ID: 11975847
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.